文献速递神经核医学

帕金森病中多巴胺与5-羟色胺转运体的纵向轨迹

Longitudinal Trajectory of Dopamine and Serotonin Transporters in Parkinson Disease.
PubMed 文献 · J Nucl Med · 2025-02-03

这项回顾性队列研究纳入127例帕金森病患者(至少两次18F-FP-CIT PET扫描)和71名年龄性别匹配的健康对照,建立时间轨迹模型估计纹状体、黑质和中缝核SBR的纵向变化。结果发现壳核和黑质18F-FP-CIT下降分别始于临床发病前11.3年和3.4年(较重侧),中缝核下降在病程20年内保持恒定;结论提示纹状体突触多巴胺转运体可用度下降约早于黑质神经元多巴胺转运体下降8年,且与运动障碍强相关。

要点

  • 帕金森病患者基线壳核和黑质18F-FP-CIT SBR显著低于对照,中缝核SBR高于对照。
  • 壳核和黑质18F-FP-CIT下降分别始于临床发病前11.3年和3.4年(较重侧)。
  • 中缝核18F-FP-CIT下降在病程长达20年内保持恒定。

核心结论

  • 结果提供体内证据:纹状体突触多巴胺转运体可用度下降约早于黑质神经元多巴胺转运体下降8年,后者与运动障碍强相关。
  • 中缝核5-羟色胺转运体可用度在疾病期间升高并基本保持不变。

研究设计与样本

  • 回顾性队列研究纳入127例帕金森病患者(至少接受两次18F-FP-CIT PET扫描)和71名年龄性别匹配的健康对照。
  • 建立时间轨迹模型估计壳核、黑质和中缝核18F-FP-CIT PET特异性结合比(SBR)从前驱期至进展期的纵向轨迹。
  • 评估SBR与年龄及运动严重程度之间的关联。

主要发现

  • 基线时帕金森病组壳核和黑质18F-FP-CIT SBR显著低于对照组,中缝核18F-FP-CIT SBR高于对照组。
  • 纵向随访中,壳核18F-FP-CIT下降始于临床发病前11.3年,黑质下降始于临床发病前3.4年(均为较重侧)。
  • 中缝核18F-FP-CIT下降在病程长达20年内保持恒定。
  • 空间分布上,黑质18F-FP-CIT SBR从尾侧和前外侧向头侧和后内侧进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Parkinson disease (PD) is a multisystem disorder marked by progressive dopaminergic neuronal degeneration in the substantia nigra, as well as nondopaminergic systems. Our aim was to investigate longitudinal changes in N-(3-[18F]fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (18F-FP-CIT) binding at the putamen, substantia nigra, and raphe nuclei in PD. Methods: This retrospective cohort study enrolled 127 patients with PD, who underwent 18F-FP-CIT PET scans twice or more, and 71 age- and sex-matched healthy controls. A temporal trajectory model was created to estimate the longitudinal trajectories of 18F-FP-CIT PET specific binding ratios (SBRs) of the putamen, substantia nigra, and raphe nuclei from the prodromal to advanced stages. Associations between SBRs and age and motor severity were evaluated. Results: At baseline, the PD group showed significantly lower 18F-FP-CIT SBR of the putamen and substantia nigra and higher 18F-FP-CIT SBR of the median raphe than did the control group. Longitudinally, 18F-FP-CIT decline of the putamen and substantia nigra began 11.3 and 3.4 y, respectively, before clinical onset on the more affected side. 18F-FP-CIT decline of the raphe nuclei remained constant for up to 20 y of disease duration. Topographically, 18F-FP-CIT SBR of the substantia nigra progressed from the caudal and anterolateral to the rostral and posteromedial regions. Conclusion: These results provide in vivo evidence of decreased striatal synaptic dopamine transporter availability approximately 8 y before decreased nigral neuronal dopamine transporter availability, which is strongly correlated with motor deficit. Serotonin transporter availability in the raphe nuclei was elevated in and remained largely unchanged during the disease span.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Song Y, Lee JH, Kim HK, et al. Longitudinal Trajectory of Dopamine and Serotonin Transporters in Parkinson Disease. J Nucl Med. 2025. PMID: 39746754. doi:10.2967/jnumed.124.268365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。